These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 767112)

  • 81. Interspersion of cyclophosphamide and BCG in the treatment of L1210 leukaemia and Lewis tumour.
    Mathé G; Halle-Pannenko O; Bourut C
    Eur J Cancer (1965); 1977 Oct; 13(10):1095-8. PubMed ID: 923609
    [No Abstract]   [Full Text] [Related]  

  • 82. BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG.
    Tracey DE; Wolfe SA; Durdik JM; Henney CS
    J Immunol; 1977 Sep; 119(3):1145-51. PubMed ID: 330748
    [No Abstract]   [Full Text] [Related]  

  • 83. Combined treatment of rodent fibrosarcoma by radiotherapy and immune adjuvant.
    Moroson H; Rotman M; Schechter M
    Int J Radiat Oncol Biol Phys; 1976; 1(3-4):267-74. PubMed ID: 786964
    [No Abstract]   [Full Text] [Related]  

  • 84. Ocular tolerance of bacillus Calmette-Guerin organisms.
    Rutgard J; Frenkel M; Peyman GA; Saks S; Stankevych A
    Arch Ophthalmol; 1977 Dec; 95(12):2210-3. PubMed ID: 337945
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Role of activated macrophages in nonspecific resistance to neoplasia.
    Hibbs JB
    J Reticuloendothel Soc; 1976 Sep; 20(3):223-31. PubMed ID: 789879
    [No Abstract]   [Full Text] [Related]  

  • 86. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8.
    Azuma I; Kanetsuna F; Taniyama T; Yamamura Y; Hori M
    Biken J; 1975 Mar; 18(1):1-13. PubMed ID: 807194
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Active immunotherapy.
    Mathé G
    Adv Cancer Res; 1971; 14():1-36. PubMed ID: 4330473
    [No Abstract]   [Full Text] [Related]  

  • 88. Active specific immunotherapy for acute myelogenous leukaemia.
    Powles R
    Johns Hopkins Med J Suppl; 1974; 3():333-40. PubMed ID: 4609353
    [No Abstract]   [Full Text] [Related]  

  • 89. Immunotherapeutic and immunoprophylactic effects of BCG on 3-methylcholanthrene-induced autochthonous tumors in Swiss mice.
    Tokunaga T; Yamamoto S; Nakamura RM; Kataoka T
    J Natl Cancer Inst; 1974 Aug; 53(2):459-63. PubMed ID: 4602061
    [No Abstract]   [Full Text] [Related]  

  • 90. Immunotherapy in previously treated acute lymphatic leukemia.
    Leventhal BG; LePourhiet A; Halterman RH; Henderson ES; Herberman RB
    Natl Cancer Inst Monogr; 1973 Dec; 39():177-87. PubMed ID: 4274495
    [No Abstract]   [Full Text] [Related]  

  • 91. Failure of BCG immunostimulation to affect the clinical course of Burkitt's lymphoma.
    Magrath IT; Ziegler JL
    Br Med J; 1976 Mar; 1(6010):615-8. PubMed ID: 766905
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The adjuvant effect of microbial products on the immune response.
    White RG
    Annu Rev Microbiol; 1976; 30():579-600. PubMed ID: 185941
    [No Abstract]   [Full Text] [Related]  

  • 93. BCG and cancer (first of two parts).
    Bast RC; Zbar B; Borsos T; Rapp HJ
    N Engl J Med; 1974 Jun; 290(25):1413-20. PubMed ID: 4364286
    [No Abstract]   [Full Text] [Related]  

  • 94. Relationship between intradermal tumor suppression and tumor immunity.
    Bartlett GL; Kreider JW; Purnell DM
    J Natl Cancer Inst; 1976 Dec; 57(6):1297-303. PubMed ID: 794505
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Liposomes as immunological adjuvants.
    Allison AC; Gregoriadis G
    Recent Results Cancer Res; 1976; (56):58-64. PubMed ID: 188085
    [No Abstract]   [Full Text] [Related]  

  • 96. Modulation of the immune response by a methanol-insoluble fraction of attenuated tubercle bacilli (BCG). I. Primary and secondary responses to sheep red blood cells and T2 phage.
    Yashphe DJ; Weiss DW
    Clin Exp Immunol; 1970 Aug; 7(2):269-81. PubMed ID: 4920606
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effect of systemic administration of BCG cell walls on bronchogenic carcinoma in hamsters.
    Zwilling BS; Springer ST; Kaufman DG
    J Natl Cancer Inst; 1977 May; 58(5):1473-7. PubMed ID: 323508
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Immunological stimulation in situ: the acute and chronic inflammatory responses in the induction of tumor immunity.
    Hanna MG; Bucana CD; Pollack VA
    Contemp Top Immunobiol; 1980; 10():267-96. PubMed ID: 6996910
    [No Abstract]   [Full Text] [Related]  

  • 99. [Immunization by Canadida albicans and non-specific immunostimulation by Corynebacterium granulosum and BCG in experimental candidiasis].
    Drouhet E; Dupont B
    C R Acad Hebd Seances Acad Sci D; 1976 Nov; 283(11 D):1385-8. PubMed ID: 825252
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Active immunotherapy of cancer for minimal residual disease: new trends and new materials.
    Mathé G; Florentin I; Olsson L; Kiger N; Bruley-Rosset M; Orbach-Arbouys S; Schulz JI
    Prog Exp Tumor Res; 1980; 25():242-74. PubMed ID: 6986635
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.